Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy
EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment
25
Participants
Timeline
Start Date
June 30, 2006
Primary Completion Date
March 31, 2013
Conditions
Breast Cancer
Interventions
DEVICE
Diffusion weighted MRI
Trial Locations (1)
48109-0944
University of Michigan Comprehensive Cancer Center, Ann Arbor
All Listed Sponsors
lead
University of Michigan Rogel Cancer Center
OTHER
NCT02679586 - Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy | Biotech Hunter | Biotech Hunter